Continuation of R&D on New Products, etc.
First written in FY2016. 29 of 33 entries say "Restated". Latest entry: FY2026.
34 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「R&D expenses for new product development were ¥61 million.」
Continued R&D for new products and other products, with annual R&D expenses reaching ¥61 million. - FY2026-H1RestatedAnnual report
「Total R&D expenses for the interim consolidated accounting period were ¥31 million. There were no material changes in the status of our group’s R&D activities during the interim consolidated accounting period.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥31 million for the interim consolidated accounting period. - FY2025-H1RestatedAnnual report
「Total R&D expenses for the interim consolidated accounting period were ¥28 million. There were no material changes in the status of our group’s R&D activities during the interim consolidated accounting period.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥28 million for the interim consolidated accounting period. - FY2024RestatedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
Reconfirmed the policy of continuing R&D. R&D expenses for new product development rose to ¥57 million. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥14 million. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥14 million for the first quarter. - FY2023Increase in R&D ExpensesAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
Reconfirmed the policy of continuing R&D. R&D expenses for new product development rose to ¥58 million, up from ¥51 million in the previous fiscal year. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥44 million. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥44 million. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥30 million. There were no material changes in the status of our group’s R&D activities during the cumulative second quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥30 million. - FY2023-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥16 million. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥16 million for the first quarter. - FY2022Decline in R&D expensesAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
Reconfirmed the policy of continuing R&D activities. R&D expenses for new product development were ¥51 million, down from ¥60 million in the previous fiscal year. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥40 million. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥40 million for the cumulative third quarter of the consolidated fiscal year. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥26 million. There were no material changes in the status of our group’s R&D activities during the cumulative second quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥26 million for the cumulative second quarter of the consolidated fiscal year. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥13 million. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥13 million for the first quarter. - FY2021RestatedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
Reconfirmed the policy of continuing independent and collaborative R&D. R&D expenses for new product development were ¥60 million. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥44 million. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥44 million for the cumulative third quarter of the consolidated fiscal year. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥28 million. There were no material changes in the status of our group’s R&D activities during the cumulative second quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥28 million for the cumulative second quarter of the consolidated fiscal year. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥14 million. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥14 million for the first quarter. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥46 million. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥46 million. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥31 million. There were no material changes in the status of our group’s R&D activities during the cumulative second quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥31 million. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the consolidated fiscal year were ¥17 million. There were no material changes in the status of our group’s R&D activities during the cumulative first quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥17 million for the first quarter. - FY2019RestatedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
Reconfirmed the policy of continuing R&D. R&D expenses were ¥60 million for the Metal Products Business and ¥1 million for the Wire and Cable Business, for a total of ¥61 million. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were ¥43 million. There were no material changes in the status of our group’s R&D activities during the cumulative third quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥43 million. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were ¥27 million. There were no material changes in the status of our group’s R&D activities during the cumulative second quarter of the consolidated fiscal year.」
Reconfirmed that there had been no material changes in R&D activities and disclosed total R&D expenses of ¥27 million for the cumulative second quarter of the consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「Under these circumstances, our group is promoting a global structure, improving quality, operational capabilities and production engineering capabilities, and continuing to develop and propose attractive products that meet society’s needs.」
Reconfirmed the policy of continuing to develop and propose products that meet society’s needs. - FY2018RestatedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time. Research and development activities by segment are as follows.」
Reconfirmed the policy of continuing independent and collaborative R&D. R&D expenses were ¥53 million for the Metal Products Business and ¥2 million for the Wire and Cable Business. - FY2018-Q3RestatedAnnual report
「Under the new management philosophy, we are working to improve our R&D, procurement and production engineering capabilities and continue developing and proposing attractive products that meet society’s needs. In product development, we are strengthening our corporate capabilities by developing the new CFRP fastener, the AluArmor® Nut.」
Reconfirmed the continued improvement of R&D capabilities and other capabilities, as well as product development and proposals. Total R&D expenses for the cumulative third quarter of the consolidated fiscal year were disclosed at ¥42 million. - FY2018-Q2RestatedAnnual report
「Under a new management philosophy, we are working to improve our research and development capabilities, purchasing capabilities, and production technology capabilities, and continue to develop and propose attractive products that society wants.」
Continued to improve capabilities in research and development, procurement and production engineering, as well as product development and proposals. Total R&D expenses for the cumulative second quarter of the consolidated fiscal year were disclosed at ¥28 million. - FY2018-Q1RestatedAnnual report
「Under a new management philosophy, we are working to improve our research and development capabilities, purchasing capabilities, and production technology capabilities, and continue to develop and propose attractive products that society wants.」
Reconfirmed the policy of continuing research and development, as well as product development and proposals. Total R&D expenses for the quarter were disclosed at ¥14 million. - FY2017RestatedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time. Research and development activities by segment are as follows.」
The policy of continuing independent or joint research and development was reaffirmed, and research and development expenses of ¥48 million for the Metal Products business and ¥2 million for the Wire and Cable business were disclosed. - FY2017-Q3RestatedAnnual report
「We continue to develop and propose attractive products that society wants.」
The policy of continuing to develop and propose products sought by society was reaffirmed. - FY2017-Q2RestatedAnnual report
「We continue to develop and propose attractive products that society wants.」
The policy of continuing to develop and propose products sought by society was reaffirmed. - FY2017-Q1RestatedAnnual report
「We continue to develop and propose attractive products that society wants.」
The policy of continuing to develop and propose products sought by society was reaffirmed. - FY2016First statedAnnual report
「We continue to conduct research and development activities for new products and other offerings independently or jointly, but there are no matters of particular note at this time.」
The policy of continuing independent or joint research and development was stated.